Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Giovanni Scambia, Maria Gabriella Ferrandina, Domenica Lorusso, Vanda Salutari, Gennaro Daniele, Laura Arenare, Carmela Pisano, Roberto Sorio, Enrico Breda, Sabino De Placido, Antonella Savarese, Francesco Raspagliesi, Pierluigi Benedetti Panici, Antonella Ferro, Anita Rimanti, Gennaro Cormio, Sabrina Chiara Cecere, Simona Scalone, Valentina Angela Marsico, Cinzia CardalesiFrancesco Cognetti, Laura Attademo, Lorenzo Guizzaro, Clorinda Schettino, Maria Carmela Piccirillo, Francesco Perrone, Ciro Gallo, Sandro Pignata

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
Original languageEnglish
Pages (from-to)83-88
JournalGynecologic Oncology
Volume154
DOIs
Publication statusPublished - 2019

Keywords

  • Chemotherapy-induced neutropenia
  • Cytotoxic dosing methods
  • Meta-analysis
  • Obstetrics and Gynecology
  • Oncology
  • Ovarian cancer
  • Prognostic factors
  • Retrospective-prospective design

Fingerprint

Dive into the research topics of 'Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials'. Together they form a unique fingerprint.

Cite this